About Microcaps
Microcaps is a company based in Zurich (Switzerland) founded in 2018 by Alessandro Ofner and Michael Hagander. It operates as a Product-as-a-Service and B2B2C. Microcaps has raised $16.2 million across 3 funding rounds from investors including Zurcher Kantonalbank, Ethereum and Helvetica Capital. Microcaps offers products and services including Perfume Pearls, Nutrition Encapsulation, Pharmaceutical Release, and Skincare Capsules. Microcaps operates in a competitive market with competitors including Biological Dynamics, Miroculus, Achira, NanoTemper and Cellix, among others.
- Headquarter Zurich, Switzerland
- Founders Alessandro Ofner, Michael Hagander
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Microcaps Ag
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$16.2 M (USD)
in 3 rounds
-
Latest Funding Round
$10.44 M (USD), Series A
Jun 07, 2024
-
Investors
Zurcher Kantonalbank
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Microcaps
Microcaps offers a comprehensive portfolio of products and services, including Perfume Pearls, Nutrition Encapsulation, Pharmaceutical Release, and Skincare Capsules.
Innovative ethanol-free perfume technology is provided for fragrances.
Natural encapsulation for nutrition products is offered for protection.
Sustained release technology for pharmaceuticals is developed and applied.
Encapsulated skincare ingredients are released precisely upon application.
People of Microcaps
Unlock access to complete
Leadership Team
1 people
Commercial Team
1 people
Software Development Team
1 people
Finance and Accounting
1 people
Unlock access to complete
Funding Insights of Microcaps
Microcaps has successfully raised a total of $16.2M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $10.44 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Microcaps
Microcaps has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Zurcher Kantonalbank, Ethereum and Helvetica Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Helvetica Capital AG is focused on investing in Swiss SMEs.
|
Locked | Locked | Locked | |
|
Health pioneers are supported through funding and innovation by Lichtsteiner Foundation.
|
Locked | Locked | Locked | |
|
University backed startup accelerator
|
Locked | Locked | Locked |
Investor details for Microcaps
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Microcaps
Investment portfolio details for Microcaps
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Microcaps
Detailed financials for Microcaps
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Microcaps Comparisons
Peer comparison for Microcaps
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Microcaps
Microcaps operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological Dynamics, Miroculus, Achira, NanoTemper and Cellix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Proprietary lab-on-chip platform for nanoparticle isolation is offered.
|
|
| Locked | Locked | Locked |
MicroRNA profiling platform is developed to detect genes in samples.
|
|
| Locked | Locked | Locked |
Provider of diagnostic medical devices for screening Covid 19
|
|
| Locked | Locked | Locked |
Develops tools for protein characterization & analysis
|
|
| Locked | Locked | Locked |
Microfluidics, biochips, and high-throughput gene-editing technologies are manufactured.
|
|
| Locked | Locked | Locked |
Microfluidic tools for protein sizing, aggregation, and interactions are developed.
|
Detailed competitors of Microcaps
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Microcaps
Complete news archive for Microcaps
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Microcaps
Microcaps was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Microcaps is headquartered in Zurich, Switzerland.
Microcaps is a funded company, having raised a total of $16.2M across 3 funding rounds to date.
Microcaps is focused on providing cutting-edge microencapsulation technologies for various industries. Solutions are developed for fine fragrances, skincare, nutrition, and pharmaceuticals. The technology is used to naturally encapsulate ingredients, offering protection and enhanced performance. Sectors served include cosmetics with ethanol-free perfume pearls, nutritional products with natural formulations, and pharmaceutical applications with sustained release methods. Partnerships are established with luxury brands to redefine market standards through innovative product experiences.
Microcaps's top competitors include Biological Dynamics, Achira and Miroculus.
Microcaps offers Perfume Pearls, Nutrition Encapsulation, Pharmaceutical Release, and Skincare Capsules.
Microcaps has 5 investors. Key investors include Zurcher Kantonalbank, Ethereum, Helvetica Capital, Lichtsteiner Foundation, and Venture Kick.